Edge Therapeutics, Inc. — Form D

Edge Therapeutics, Inc. of NEW PROVIDENCE, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2015-04-09. The offering totals $56.0M, of which $56.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (38)

Showing 25 of 38 people.

NameRoleLocation
Sol J BarerDirectorMendham, NJ
Isaac J BlechDirectorBOSTON, MA
Kurt J ContiDirectorBerkeley Heights, NJ
Brian A LeuthnerDirectorBerkeley Heights, NJ
James J LoughlinDirectorBerkeley Heights, NJ
Robert Loch MacdonaldDirectorBerkeley Heights, NJ
Robert J SpiegelDirectorBerkeley Heights, NJ
Andrew Loch EinhornExecutive OfficerBerkeley Heights, NJ
Herbert J FaleckExecutive OfficerBerkeley Heights, NJ
Brian A LeuthnerExecutive OfficerBerkeley Heights, NJ
Robert Loch MacdonaldExecutive OfficerBerkeley Heights, NJ
Albert N Marchio IIExecutive OfficerBerkeley Heights, NJ
Carl J SorannoExecutive OfficerBerkeley Heights, NJ
Sol BarerDirectorNew Providence, NJ
Robert Loch MacdonaldPromoterBerkeley Heights, NJ
Carl J SorannoDirectorBerkeley Heights, NJ
Carl J SorannoPromoterBerkeley Heights, NJ
Brian A LeuthnerPromoterBerkeley Heights, NJ
Priya Loch JambhekarExecutive OfficerNew Providence, NJ
Isaac Loch BlechDirectorNew Providence, NJ
Kurt ContiDirectorNew Providence, NJ
Brian LeuthnerDirectorNew Providence, NJ
Brian LeuthnerExecutive OfficerNew Providence, NJ
Brian LeuthnerPromoterNew Providence, NJ
R Loch McDonaldDirectorNEWARK, NJ

Other filings by this issuer (6)

FiledFormOfferingSold
2014-11-13D$25.0M$7.9M
2013-03-25D$20.0M$6.7M
2012-09-17D$3.0M$119K
2011-06-24D$2.8M$220K
2010-11-08D/A$2.0M$635K
2009-09-16D$2.0M$500K

More